Patients in Europe are waiting longer to access medicines than patients in the US, a new report warns.  The European Federation of Pharmaceutical Industries and Associations (EFPIA)’s report shows 49% of FDA-approved medicines are not available in Europe, up from 46% in 2019.  Data also indicates 17% of medicines are only available in Europe under […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!